Trastuzumab (International)

In the US, Trastuzumab (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

• Trastuzumab
• Trastuzumab and hyaluronidase-oysk
• Trastuzumab-anns
• Trastuzumab-dkst
• Trastuzumab-dttb
• Trastuzumab-pkrb

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC03

CAS registry number (Chemical Abstracts Service)

0180288-69-1

Chemical Formula

C6470-H10012-N1726-O2013-S42

Therapeutic Categories

Antineoplastic agent

Biological response modifier, BRM

Immunomodulator

Anti-HER2 monoclonal antibody

Chemical Name

Immunoglobulin G1 (human-mouse monoclonal rhuMab HER2γ₁-chain antihuman p185c-erbB²receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer (WHO )

Foreign Names

• Trastuzumabum (Latin)
• Trastuzumab (German)
• Trastuzumab (French)
• Trastuzumab (Spanish)

Generic Names

• Trastuzumab (OS: BAN, USAN, DCF)
• Trastuzumab (Genetical Recombination) (OS: JAN)
• Anti-HER-2 monoclonal antibody (IS)
• MAB anti-HER-2 (IS)
• UNII-P188ANX8CK (IS)
• Trastuzumab Emtansine (OS: USAN)
• Trastuzumab Emtansine (Genetical Recombination) (OS: JAN)
• ado-Trastuzumab emtansine (IS)
• PRO 132365 (IS)
• T-DM 1 (IS)
• Trastuzumab-MCC-DM 1 (IS)
• UNII-SE2KH7T06F (IS)

Brand Names

• Herceptin
  Chugai Pharmaceutical, Japan; F. Hoffmann-La Roche LTD, Serbia; Genentech, Georgia; Genentech, United States; Genentech Inc., Oman; Hoffmann La Roche, Kuwait; Hoffmann-La Roche, Canada; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche Pharmaceutical, China; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Registration, Slovenia; Roche Uruguay, Uruguay
• Herceptin 150mg
  Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Herceptin 440mg
  Roche Pharma Schweiz, Switzerland
• Herceptin 600mg
  Abacus, Austria; Haemato Pharm, Austria; Orifarm, Austria; Roche, Hungary; Roche Registration, Austria
• Herceptin 600mg/5ml
  Roche, Luxembourg; Roche Pharma Schweiz, Switzerland
• Herceptin SC
  Productos Roche, Chile; Roche, New Zealand; Roche Products, Australia
• Herceptin SC 600mg/5ml
  Roche, Israel
• Hertraz
  Biocon, Georgia
• Herzuma
  Celltrion, Slovenia
• Kadcyla
  Productos Roche, Chile; Roche, Bosnia & Herzegowina; Roche, Cyprus; Roche, Croatia (Hrvatska); Roche, Poland; Roche, Turkey; Roche Farma, Peru; Roche Registration Limited, Iceland
• Kadcyla 160mg
  Roche, Hungary
• Kanjinti
  Amgen Europe, Netherlands; Amgen Europe, Slovenia
• Ontruzant
  Samsung Bioepis, Latvia; Samsung Bioepis UK, Netherlands
• Perjeta-Herceptin [+ Pertuzumab]
  Hoffmann-La Roche, Canada
• Trastuzumab Baxter
  Baxter, New Zealand
• Zedora
  Libbs, Brazil
• Kadcyla
  Chugai Pharmaceutical, Japan; DSM Pharmaceuticals, Georgia; F. Hoffmann-La Roche LTD, Serbia; Genentech, United States; Hoffmann-La Roche, Canada; Roche, Argentina; Roche, Belgium; Roche, Brazil; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Estonia; Roche, Spain; Roche, Finland; Roche, France; Roche, Hong Kong; Roche, Ireland; Roche, Israel; Roche, Lithuania; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Sweden; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Ltd, Greece; Roche Registration, Slovenia
• Kadcyla 100mg
  Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Kadcyla 160mg
  Orifarm, Austria; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Trazimera
  Pfizer, Netherlands

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer